Related Experiment Video
Updated: Apr 26, 2026

Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Krüppel-like factor 8 contributes to hypoxia-induced MDR in gastric cancer cells
1Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China; Department of Tuberculosis Control and Prevention, Xi'an Center for Disease Control and Prevention, Xi'an, China.
Abstract:
We previously reported that hypoxia-induced MDR in gastric cancer (GC) cells is hypoxia-inducible factor-1 (HIF-1)-dependent. However, the exact mechanisms are still unknown. Our previous study revealed that Krüppel-like factor 8 (KLF8), a novel transcription factor, was associated with malignant phenotype in GC cells. KLF8 is overexpressed in clear cell renal carcinoma lacking von Hippel-Lindau protein function, which resulted in HIF-1 stabilization. Given this association, we hypothesized that KLF8 contributed to hypoxia-induced MDR in GC cells. Initial experiments revealed that hypoxia could increase KLF8 and HIF-1α expressions in GC cells, and KLF8 levels in GC drug-resistant cell lines were higher than in parental cell lines. Subsequent experiments showed that in normoxia, exogenous KLF8 could promote the MDR phenotype; however, blocking KLF8 expression could effectively reverse the MDR phenotype induced by hypoxia. Overexpressed KLF8 increased resistance-associated gene MDR1 mRNA levels, Bcl-2 and P-gp protein levels, and decreased Bax and caspase-3 protein levels in GC cells, and knockout KLF8 reversed these effects. Dual luciferase reporter and ChIP assays showed that KLF8 could promote MDR1 transcriptional activity by combining with KLF8 binding sites located in the upstream of MDR1 transcriptional start site. These results suggest that KLF8 is involved in hypoxia-induced MDR through inhibiting apoptosis and increasing the drug release rate by directly regulating MDR1 transcription.
Insights
Krüppel-like factor 8 (KLF8) drives multidrug resistance (MDR) in gastric cancer (GC) cells under hypoxia. KLF8 directly enhances MDR1 transcription, inhibiting apoptosis and increasing drug resistance.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Hypoxia-induced multidrug resistance (MDR) in gastric cancer (GC) is linked to hypoxia-inducible factor-1 (HIF-1).
- Krüppel-like factor 8 (KLF8), a transcription factor, is associated with GC malignancy and overexpressed in certain cancers with HIF-1 stabilization.
Purpose of the Study:
- To investigate the role of KLF8 in hypoxia-induced MDR in gastric cancer cells.
- To elucidate the molecular mechanisms by which KLF8 contributes to MDR.
Main Methods:
- Assessed KLF8 and HIF-1α expression under hypoxia in GC cells.
- Expressed or blocked KLF8 in GC cells under normoxia and hypoxia.
- Measured MDR1 mRNA, Bcl-2, P-gp, Bax, and caspase-3 protein levels.
- Utilized dual luciferase reporter and ChIP assays to determine KLF8's effect on MDR1 transcription.
Main Results:
- Hypoxia increased KLF8 and HIF-1α expression in GC cells; KLF8 levels were higher in drug-resistant GC lines.
- Exogenous KLF8 promoted MDR in normoxia, while blocking KLF8 reversed hypoxia-induced MDR.
- KLF8 overexpression increased MDR1, Bcl-2, and P-gp, while decreasing Bax and caspase-3; KLF8 knockout reversed these effects.
- KLF8 directly promoted MDR1 transcription via binding sites upstream of the MDR1 transcriptional start site.
Conclusions:
- KLF8 plays a critical role in hypoxia-induced MDR in gastric cancer.
- KLF8 inhibits apoptosis and enhances drug efflux by directly regulating MDR1 transcription, contributing to chemoresistance.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Angiogenesis and Blood Supply
Treatment Resistant Cancers
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

